New combo therapy aims to boost immune system against liver cancer before surgery
NCT ID NCT04857684
Summary
This is a small, early-stage study testing a new treatment approach for liver cancer that can be removed by surgery. Researchers want to see if giving a combination of targeted radiation and two immunotherapy drugs *before* the operation is safe and might help the body's immune system better fight the cancer. The goal is to see if this approach could lower the chance of the cancer coming back after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.